Total submissions: 4
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Labcorp Genetics |
RCV000912465 | SCV001057573 | benign | not provided | 2024-01-15 | criteria provided, single submitter | clinical testing | |
Fulgent Genetics, |
RCV002479056 | SCV002802620 | likely benign | Ventriculomegaly-cystic kidney disease; Focal segmental glomerulosclerosis 9 | 2022-05-18 | criteria provided, single submitter | clinical testing | |
Breakthrough Genomics, |
RCV000912465 | SCV005320506 | benign | not provided | criteria provided, single submitter | not provided | ||
Prevention |
RCV004551794 | SCV004750669 | likely benign | CRB2-related disorder | 2020-10-22 | no assertion criteria provided | clinical testing | This variant is classified as likely benign based on ACMG/AMP sequence variant interpretation guidelines (Richards et al. 2015 PMID: 25741868, with internal and published modifications). |